184 related articles for article (PubMed ID: 29796601)
1. Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease.
Oka T; Hamano T; Sakaguchi Y; Yamaguchi S; Kubota K; Senda M; Yonemoto S; Shimada K; Matsumoto A; Hashimoto N; Mori D; Monden C; Takahashi A; Obi Y; Yamamoto R; Takabatake Y; Kaimori JY; Moriyama T; Horio M; Matsui I; Isaka Y
Nephrol Dial Transplant; 2019 Jul; 34(7):1154-1162. PubMed ID: 29796601
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
[TBL] [Abstract][Full Text] [Related]
3. The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study.
Toprak O; Sarı Y; Koç A; Sarı E; Kırık A
Clin Interv Aging; 2017; 12():437-444. PubMed ID: 28280316
[TBL] [Abstract][Full Text] [Related]
4. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
[TBL] [Abstract][Full Text] [Related]
5. Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial.
Wu MT; Tung SC; Hsu KT; Lee CT
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):271-7. PubMed ID: 23223162
[TBL] [Abstract][Full Text] [Related]
6. The effect of interactions between proteinuria, activity of fibroblast growth factor 23 and serum phosphate on renal progression in patients with chronic kidney disease: a result from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease study.
Kim H; Park J; Nam KH; Jhee JH; Yun HR; Park JT; Han SH; Chung W; Oh KH; Park SK; Kim SW; Kang SW; Choi KH; Ahn C; Yoo TH
Nephrol Dial Transplant; 2020 Mar; 35(3):438-446. PubMed ID: 30615179
[TBL] [Abstract][Full Text] [Related]
7. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
8. Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin.
Lam M; Adelstein DJ
Am J Kidney Dis; 1986 Sep; 8(3):164-9. PubMed ID: 3752072
[TBL] [Abstract][Full Text] [Related]
9. Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.
Tynkevich E; Flamant M; Haymann JP; Metzger M; Thervet E; Boffa JJ; Vrtovsnik F; Houillier P; Froissart M; Stengel B;
Nephrol Dial Transplant; 2015 Aug; 30(8):1386-94. PubMed ID: 25817225
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression.
Ying T; Clayton P; Naresh C; Chadban S
BMC Nephrol; 2018 Mar; 19(1):55. PubMed ID: 29514605
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.
Sakaguchi Y; Hamano T; Obi Y; Monden C; Oka T; Yamaguchi S; Matsui I; Hashimoto N; Matsumoto A; Shimada K; Takabatake Y; Takahashi A; Kaimori JY; Moriyama T; Yamamoto R; Horio M; Yamamoto K; Sugimoto K; Rakugi H; Isaka Y
J Am Soc Nephrol; 2019 Jun; 30(6):1073-1085. PubMed ID: 31036759
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.
Schulman G; Berl T; Beck GJ; Remuzzi G; Ritz E; Shimizu M; Kikuchi M; Shobu Y
Clin Exp Nephrol; 2018 Apr; 22(2):299-308. PubMed ID: 28741050
[TBL] [Abstract][Full Text] [Related]
13. Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).
Sofue T; Nakagawa N; Kanda E; Nagasu H; Matsushita K; Nangaku M; Maruyama S; Wada T; Terada Y; Yamagata K; Narita I; Yanagita M; Sugiyama H; Shigematsu T; Ito T; Tamura K; Isaka Y; Okada H; Tsuruya K; Yokoyama H; Nakashima N; Kataoka H; Ohe K; Okada M; Kashihara N
PLoS One; 2020; 15(10):e0240402. PubMed ID: 33057377
[TBL] [Abstract][Full Text] [Related]
14. Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk.
Dey R; Rajappa M; Parameswaran S; Revathy G
Clin Exp Nephrol; 2015 Dec; 19(6):1054-61. PubMed ID: 25697595
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fractional excretion of electrolytes in patients at different stages of chronic kidney disease: A cross-sectional study.
Hsiao PJ; Liao CY; Kao YH; Chan JS; Lin YF; Chuu CP; Chen JS
Medicine (Baltimore); 2020 Jan; 99(2):e18709. PubMed ID: 31914079
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of chronic kidney disease (CKD) and significant contributors to CKD in HIV-infected patients].
Nakamura Y; Shibuya A; Suzuki H; Ando M
Nihon Jinzo Gakkai Shi; 2008; 50(4):499-505. PubMed ID: 18546881
[TBL] [Abstract][Full Text] [Related]
17. Body mass index modifies the effect of urinary protein-to-creatinine ratio on chronic kidney disease progression.
Wang J; Fan Q; Hu Y; Zhu L; Xu J
Int Urol Nephrol; 2024 Jul; 56(7):2371-2378. PubMed ID: 38407753
[TBL] [Abstract][Full Text] [Related]
18. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
Tanaka H; Hamano T; Fujii N; Tomida K; Matsui I; Mikami S; Nagasawa Y; Ito T; Moriyama T; Horio M; Imai E; Isaka Y; Rakugi H
Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
[TBL] [Abstract][Full Text] [Related]
19. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.
Felsenfeld AJ; Levine BS; Rodriguez M
Semin Dial; 2015; 28(6):564-77. PubMed ID: 26303319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
